Ureaplasma are associated with numerous clinical sequelae with treatment options being limited due 19 to patient and pathogen factors. This report examines the prevalence and mechanisms of antibiotic 20 resistance among clinical strains isolated from 95 neonates, 32 women attending sexual health clinic 21 and 3 patients under investigation for immunological disorders, between 2007 -2013 in England and
Results: 106 
Prevalence of resistance 107
Using the adapted broth microdilution technique we were able to identify two isolates resistant to 108 ciprofloxacin (U6 32 µg/mL and HPA116 16 µg/mL), and three isolates which were tetracycline 109 resistant (Table 1) . This gave a prevalence of resistance of 1.5% (CI + 2.09) and 2.3% (CI + 2.58), 110 respectively, for each antibiotic. No breakpoint values for resistance of ciprofloxacin are available in 111 the CLSI guidelines (20); however, published breakpoints for moxifloxacin and levofloxacin indicate 112 resistance to be ≥ 4 µg/mL. Both strains U6 and HPA116 were more sensitive to moxifloxacin (1 113 µg/mL) and levofloxacin (2 µg/mL) ( Table 2) , but these values were still higher than our susceptible 114 strains: ≤0.25 µg/mL for moxifloxacin and ≤0.5 µg/mL for levofloxacin (data not shown). All 130 115 isolates were sensitive to the macrolide antibiotics erythromycin and azithromycin as well as 116 chloramphenicol. All strains had an intrinsically high MIC for gentamicin (mean values of 42 µg/mL 117 U. parvum and 66 µg/mLl U. urealyticum). No co-resistant strains were identified. The mean MIC of 118 all antibiotics was significantly higher for U. urealyticum than U. parvum with exception of 119 chloramphenicol and azithromycin (Table 3) . 
Screening for tetracycline resistance gene 122
Tetracycline resistance is well characterized among Ureaplasma species and is associated with the 123 presence of the horizontally acquired tet(M) resistance gene. We screened DNA isolated from all 124 isolates by PCR for the presence of the tet(M) gene and identified three positive strains of the 130 125 isolates (Table 4) . Interestingly, broth culture screening for tetracycline resistance only identified two 126 of these isolates (HPA111, MIC = 64 and Ply157, MIC = 8), while the third tet(M)-positive isolate 127 was initially sensitive to tetracycline (HPA71 MIC = 1). However, subculture from the lowest sub-128 inhibitory concentration of tetracycline found increased MIC for HPA111 (MIC >64) and Ply157 129 (MIC=64), while HPA71 remained sensitive (MIC=2). A second serial challenge with tetracycline 130 found that resistance had been induced for HPA71 (MIC=64). This induction of resistance in HPA71 131 was repeated twice with identical results. Therefore, screening for the presence of the tet(M) gene is 132 less likely to miss resistant isolates than microbroth dilution methods for tetracycline resistance. We 133 sequenced the 3' region of the tet(M) gene for the three isolates identified as tet(M) positive (two 134 phenotypically resistant, one initially phenotypically sensitive). From this we identified that HPA71 135 and HPA111 were most closely related to the previous Vancouver SV9 sequence, whereas Ply157 136 was a chimera of both Vancouver and Seattle sequences (Table 4 ). No mutations within the 3' region 137 were identified to explain the required induction of tetracycline resistance for HPA71 (accession 138 number KT267561). Susceptibility to doxycycline was similar to that observed for tetracycline for the 139 resistant isolates (Table 2 ).
141
Molecular mechanism for ciprofloxacin resistance 142 Molecular characterization was undertaken on two identified ciprofloxacin resistant isolates using 
Identification of resistance using the MIST2 test 148
The bioMérieux Mycoplasma IST2 kit was used to screen a subset of twenty submitted samples and 149 the results for resistance to a spectrum of biologically active antibiotics. From the 20 samples 150 examined 8 were found to be Ureaplasma spp. positive and all gave a reading of resistance to both the 151 lower (1 µg/mL) and higher (2 µg/mL) levels for ciprofloxacin. The assay also showed that all 152
Ureaplasma were able to grow in 1 µg/mL of ofloxacin, but not the higher 4 µg/mL concentration. 153
However, using the accepted international MIC broth microdilution technique, repeated in duplicate, 154 three of these ciprofloxacin isolates had an MIC = 1 µg/mL (identified as U. parvum), three had an 155 MIC = 2 µg/mL (identified as U. parvum) and two had an MIC = 4 µg/mL (identified as U. 156 urealyticum). The microbroth dilution values determined that all of these isolates were sensitive to 157 ciprofloxacin and consistent with the MIC90 for their respective species (Table 3) . to harbor the predominant quinolone resistance determining mutation S83L. This mutation has been 205 described numerous times from patient cohorts from the USA, China and France, but this is the first 206 description among UK isolates (1, 11, 22, 25). As the mechanism for quinolone resistance is mutation 207 driven and not horizontally transferred, the likelihood of spread is limited as it would be clonal and 208 could account for the relatively low level of resistance within these organisms.
210
Tetracycline resistance is well characterized among Ureaplasma and mediated via the acquisition of 211 the tet(M) resistance element giving ribosomal protection (7). As expected all tetracycline resistant 212 strains in this study were positive for tet(M) in addition to a tetracycline sensitive isolate (HPA71).
213
By characterizing tet(M) positive strains it is possible to track the emergence of new sequence 214 variants within the UK. From these data we identified two out of three tet(M) positive strains to be 215 identical to the Vancouver sequence which we have previously described in the UK, but curiously the 216 tet(M) sequence of isolate Ply157 was a chimera of both Vancouver and Seattle strains. This is 217 unlikely an artifact as it was confirmed by multiple sequencing experiments performed on this isolate.
218
As with our study in 2009 we identified a single isolate which was tet(M) positive, but phenotypically 219 sensitive to the antibiotic (HPA71). We were successful in inducing expression and resultant 220 resistance for this strain (but not other sensitive strains examined in parallel) with the presence of low µg/mL) concentrations of ciprofloxacin provided in the kit (14) . However, broth microdilution 238 evaluation of these found that three of the isolates had an MIC = 1 µg/ml and 3 of the isolates had an 239 MIC = 2 µg/mL. All of these isolates were U. parvum. The remaining two isolates were U. 240 urealyticum and had an MIC = 4 µg/mL which is within keeping with the slightly higher CI95 241 determined to be between 2.64-3.66 µg/mL for ciprofloxacin. Therefore, none of the isolates were 242 actually resistant to ciprofloxacin, relative to normal sensitivity ranges for the organisms tested and England and Wales to vigilance in keeping antibiotic prescription to a minimum, the geographic 251 differential in antibiotic resistance is unlikely to be maintained, particularly with increasing travel 252 between countries in combination with the increased prescribing of macrolide antibiotics for N. 
